SYDNEY, AUSTRALIA – Initiative continues to strengthen its foothold in the healthcare sector, securing Aspen Pharmacare Australia as its newest client after a fiercely contested pitch. The media agency will now lead media strategy, planning, and buying across Aspen’s portfolio of trusted consumer healthcare brands, including Maltofer, Coloxyl, Ural, and Dymadon.
As one of Australia’s leading consumer healthcare companies, Aspen is on an ambitious growth trajectory in a highly competitive and tightly regulated market. Initiative is set to power the brand’s next phase of expansion through its industry-leading tools and cutting-edge media solutions.
Jo McAlister, CEO Initiative said Aspen Australia’s entrepreneurial spirit aligns perfectly with Initiative’s culture and people and already the collaboration between the teams is evident.
McAlister said: “Aspen Pharmacare operates with a core mantra to provide all Australians with access to a great range of high-quality healthcare products. We are motivated to utilise our industry-leading tools to create new thinking and develop effective campaigns that are a cut above their competitors and will help the company achieve its growth goals.”
McAlister continued: We look forward to elevating the company as it enters a new evolution of growth.”
Alison Holland, Head of Consumer OTC at Aspen Pharmacare said: “We are thrilled to partner with Initiative to enhance our consumer engagement and drive impactful connections in the healthcare space. This collaboration aligns with our commitment to delivering innovative, patient-centric solutions through strategic and data-driven media approaches.
“We look forward to exciting times ahead as Aspen Pharmacare benefits from the fresh, exciting media thinking Initiative is renowned for,” she concluded.
The transition is already underway with the partnership live from April 1. The first work will be in market Q3.
